Fujita Health University Reports Findings in Gastric Cancer (Robotic gastrectomy for gastric cancer: systematic review and future directions): Oncology – Gastric Cancer

Japan Daily Report

2023 APR 14 (NewsRx) -- By a News Reporter-Staff News Editor at Japan Daily Report -- New research on Oncology - Gastric Cancer is the subject of a report. According to news reporting from Aichi, Japan, by NewsRx journalists, research stated, “Robotic gastrectomy (RG) using the da Vinci Surgical System for gastric cancer was approved for national medical insurance coverage in Japan in April 2018, and its number has been rapidly increasing since then. We reviewed and compared current evidence on RG and conventional laparoscopic gastrectomy (LG) to identify the differences in surgical outcomes.”

The news correspondents obtained a quote from the research from Fujita Health University, “Three independent reviewers systematically reviewed the data collected from a comprehensive literature search by an independent organization, focusing on the following nine endpoints: mortality, morbidity, operative time, estimated blood loss volume, length of postoperative hospital stay, long-term oncologic outcome, quality of life, learning curve, and cost. Compared to LG, RG has lower intraoperative blood loss volume, shorter length of hospital stay, and shorter learning curve, but both procedures have similar mortality. Contrarily, its disadvantages include longer procedural time and higher costs. Although the morbidity rate and long-term outcomes are almost comparable, RG showed superior potentials. Currently, the outcomes of RG are considered comparable to or better than LG.”

According to the news reporters, the research concluded: “RG might be applicable to all gastric cancer patients who fulfill the indication of LG at institutions that meet specific criteria and are approved to claim the National Health Insurance costs for the use of the surgical robot in Japan.”

This research has been peer-reviewed.

For more information on this research see: Robotic gastrectomy for gastric cancer: systematic review and future directions. Gastric Cancer, 2023. Gastric Cancer can be contacted at: Springer, One New York Plaza, Suite 4600, New York, Ny, United States. (Springer - www.springer.com; Gastric Cancer - http://www.springerlink.com/content/1436-3291/)

Our news journalists report that additional information may be obtained by contacting Susumu Shibasaki, Dept. of Surgery, Fujita Health University, 1-98 Dengakugakubo, Kutsukake, Toyoake, Aichi, 470-1192, Japan. Additional authors for this research include Koichi Suda, Shigeo Hisamori, Kazutaka Obama, Masanori Terashima and Ichiro Uyama.